Login | Register

FDA announces new labeling and safety rules for opioids

The US Food and Drug Administration (FDA) has announced it will make changes to safety labeling and post-market study requirements for extended-release and long-acting opioids. Opioids are a commonly used class of narcotic pain medication. They work by binding to specific proteins called opioid receptors that are located in the brain, spinal cord and gastrointestinal tract...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *